Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
June 30, 2025: Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Search
Professional Education
Delayed, Wrong, or Missed: Diagnostic Process Failure in Nurse Practitioner Practice
Diagnostic process failure resulting in delayed, wrong, or missed diagnoses has been identified as a serious and often preventable harm in healthcare. To prevent diagnostic error, nurse practitioners (NPs) should be aware of the most misdiagnosed conditions and understand the risks associated with cognitive bias. This course will help NPs understand the 12-step diagnostic process of care framework and determine where contributing factors exist in their primary practice setting to effectively recognize and implement appropriate improvement strategies.
Dec 02, 2024
Foundation Announces 2024 Grant Recipients
The Doctors Company Foundation awarded three new grants in 2024.
From
The Doctor’s Advocate
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Professional Education
Anesthesia: Diagnosis and Management of Posterior Anterior Neck Hematoma
Anterior neck hematoma (ANH) is a serious emergency that can block the airway and endanger the life of a patient who has had neck surgery. Anesthesia professionals need to be ready to identify ANH and act when there is no surgeon nearby. This course covers recognizing the signs and symptoms of postoperative ANH and strategies for response.
Supporting Pediatric Cancer Research
The employees of TDC Group—The Doctors Company, Healthcare Risk Advisors, TDC Specialty Underwriters, and Medical Advantage—consistently demonstrate their generosity to the causes they care most about. Many seek matching funds from the TDC Group Employee Gift Matching Program to double their donations to causes they care about.
March 01, 2024, Healthcare Risk Management
AI Creates Liability Risks for Healthcare Organizations
Sue Boisvert, BSN, MHSA, CPPS, CPHRM, DFASHRM, Senior Patient Safety Risk Manager, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, discusses how artificial intelligence (AI) is becoming more common in healthcare, and while it offers substantial benefits, there are serious risks to consider.
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
